The Top 20 Companies In The Advanced Wound Care Market 2013-2023

News provided by

Sep 30, 2013, 08:02 ET

NEW YORK, Sept. 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Top 20 Companies In The Advanced Wound Care Market 2013-2023
http://www.reportlinker.com/p01657657/The-Top-20-Companies-In-The-Advanced-Wound-Care-Market-2013-2023.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

Report Details

Advanced Wound Care - assess products, developments, and revenue prospects

How are companies in the advanced wound care market performing? Visiongain's updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.

Our study lets you assess leading companies in the advanced wound care market, showing their prospects to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions. You will also find information on both established and rising companies.
Forecasts and other data to help you stay ahead

In our new study you find analytical profiles of 20 top companies - and analyses of the overall industry and leading segments - with historical data, revenue forecasts, growth rates, and market shares. Discover qualitative analysis too. You also gain 97 figures, 62 tables and interviews with two leading companies in the advanced wound care market.

Our work lets you assess the most lucrative parts of the world industry for advanced wound care products. See now how you can benefit your research, analyses, and decisions there, also saving time.

The following sections highlight what you find in our new investigation.

Assessments of top companies - activities, results, competition, and potential sales

Our report analyses the top 20 manufacturers of advanced wound care products. In general a company profile gives you the following information:
• Overview of the company, including its history in the advanced wound care market
• Discussion of a company's activities, outlook, and recent financial results
• Assessment of its developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
• Qualitative analysis of the company, identifying strengths over its competitors, as well as potential threats to sales growth

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for the world advanced wound care market and its submarkets

First, our study gives you discussions, commercial outlooks and revenue forecasts for three advanced wound care submarkets to 2023:
• Moist Wound Care
• Wound Care Devices
• Wound Care Biologics

How will those advanced wound care markets expand? Which applications will generate most money? You investigate that industry, finding the most promising places for investments and sales.

North America - outlooks for leading companies in the advanced wound care market

Next, our report analyses 9 North American advanced wound care specialists, including these:
• 3M
• ConvaTec
• Derma Sciences
• Hollister Incorporated
• Human Biosciences.

There you find where sales growth can occur. Many opportunities remain, with high, expanding revenues possible from 2013. See where best potentials exist.

Europe - prospects for leading companies in the advanced wound care market

You also discover outlooks for 11 European advanced wound care specialists, including these:
• Smith & Nephew
• B.Braun Melsungen
• Coloplast
• Genzyme
• Molnlycke Health Care

Our report shows you how companies can seize opportunities and expand their businesses.

Issues affecting the manufacturing and selling of advanced wound care products

In addition, our report discusses issues and events affecting that industry and market from 2013, including these:
• Traditional wound care - loosing market share with the growth of AWC
• AWC Market - witnessing a rise in M&A Activity
• Wound care biologics - taking centre stage with new bioactive products
• AWC Market driven by an aging population
• Expansion internationally - targeting emerging national markets
• Stem cells and Gene therapy - offer opportunities for growth
• High rivalry among competitors

There you explore the advanced wound care industry's strengths, weaknesses, opportunities, and threats. Discover now what the future holds.

Ways The Top 20 Companies in the Advanced Wound Care Market 2013-2023 helps you

In summary, then, our new research and analysis give you the following knowledge:
• Revenues to 2023 for the world advanced wound care market and its submarkets - discover that industry's prospects, finding promising places for investments and revenues
• Profiles of 20 leading companies - assess product ranges, strategies, financial results and commercial outlook to 2023.
• Competition and opportunities - see what affects the advanced wound care market, learning what shapes its future, esp. prospects for sustaining and developing business
• Analysis of what stimulates and restrains the advanced wound care industry - discover challenges and strengths, helping you compete and gain advantages
• Issues affecting established competitors and firms entering the advanced wound care sector - explore needs, practices, and outlooks for future success.

Information found nowhere else

That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.

With our new survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

1. Executive Summary

1.1 Overview
1.2 Leading AWC Manufacturers: Overview of Findings
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Relating to Advanced Wound Care

2. Introduction

2.1 What is a Wound?
2.2 Wound Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Increasing Prevalence of Chronic Wounds
2.2.3 Burns
2.3 The Skin
2.4 The Phases of Wound Healing
2.4.1 The Inflammatory Phase
2.4.2 The Proliferation Phase
2.4.3 The Fibroblastic Phase
2.4.4 The Maturation Phase
2.5 Wound Care
2.5.1 Role of Wound Dressing
2.6 The History of Wound Care
2.7 Wound Care Categories
2.7.1 Traditional Wound Care
2.7.1.1 Gauze Dressings
2.7.1.2 Absorptive Dressings
2.7.1.3 Composite Dressings
2.7.1.4 Compression Therapy
2.7.1.5 Contact Layers
2.7.2 Advanced Wound Care (AWC)
2.7.2.1 Moist Wound Care (MWC)
2.7.2.1.1 Hydrocolloid Dressings
2.7.2.1.2 Foam Dressings
2.7.2.1.3 Alginate Dressings
2.7.2.1.4 Hydrogel Dressings
2.7.2.2 Wound Care Devices
2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.7.2.2.2 Ultrasound for Wound Therapy
2.7.2.3 Wound Care Biologics
2.7.2.3.1 Skin Replacement Therapies
2.7.2.3.2 Collagen Based Therapies
2.7.2.3.3 Cell Based Therapies
2.8 Regulation of Medical Devices
2.8.1 The US Regulation System
2.8.2 The European Approval and Regulation Process

3. The Global Advanced Wound Care Market, 2013-2023

3.1 Global Wound Care Market, 2012
3.2 Global Wound Care Market Trends, 2012
3.3 Advanced Wound Care Market, 2012
3.4 Global Advanced Wound Care Market Forecast, 2012-2023
3.5 Advanced Wound Care Market: Drivers and Restrains, 2013-2023
3.6 Leading Advanced Wound Care Manufacturers, 2012

4. The Moist Wound Care Market, 2013-2023

4.1 The Moist Wound Care Market, 2012
4.2 The Moist Wound Care Market Forecast, 2012-2023
4.3 The Moist Wound Care Market Segments, 2012
4.3.1 The Hydrocolloid Dressings Market
4.3.2 The Foam Dressings Market
4.3.3 The Alginate Dressings Market
4.3.4 The Hydrogel Dressings Market
4.3.5 Other MWC Dressings Market
4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
4.4.1 Strengths
4.4.1.1 Established Segment of the Market
4.4.1.2 Wide Variety of Products
4.4.1.3 More Effective than Traditional Wound Care
4.4.2 Weaknesses
4.4.2.1 Less Effective than Some Devices and Biologics
4.4.2.2 Weak R&D Pipeline
4.4.3 Opportunities
4.4.3.1 Increasing Prevalence of Chronic Wounds
4.4.3.2 Cheap Alternative to Devices and Biologics
4.4.4 Threats
4.4.4.1 Emerging Technologies May be More Effective
4.4.4.2 Lack of R&D Spending will Stifle Innovation

5. The Wound Care Devices Market, 2013-2023

5.1 The Wound Care Devices Market, 2012
5.2 The Wound Care Devices Forecast, 2012-2023
5.3 The NPWT Segment Dominates Wound Care Devices Market
5.3.1 The NPWT Market Forecast, 2012-2023
5.4 Ultrasound Wound Therapy Market offers Potential for Growth
5.4.1 Ultrasound Wound Therapy Market Forecast, 2012-2023
5.5 SWOT Analysis of the Wound Care Devices Market, 2013-2023
5.5.1 Strengths
5.5.1.1 More Effective than Other Forms of Wound Care
5.5.1.2 Constant Innovation in the Market
5.5.2 Weaknesses
5.5.2.1 Dominated by Few Large Companies
5.5.2.2 NPWT Dominates the Market
5.5.3 Opportunities
5.5.3.1 Low Cost NPWT Systems will Drive Growth
5.5.3.2 Increasing Prevalence of Chronic Wounds
5.5.4 Threats
5.5.4.1 Controversy Regarding Safety of NPWT

6. The Wound Care Biologics Market, 2013-2023

6.1 The Wound Care Biologics Market, 2012
6.2 The Wound Care Biologics Market Forecast, 2012-2023
6.3 The Skin Replacement Market: High Potential for Growth
6.3.1 The Skin Replacement Market Forecast, 2012-2023
6.4 Collagen Based Therapy Market
6.4.1 Collagen Based Therapy Market Forecast, 2012-2023
6.5 Cell Therapy Market: Fastest Growing Segment
6.5.1 Cell Therapy Market Forecast, 2012-2023
6.6 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
6.6.1 Strengths
6.6.1.1 More Effective than Other Forms of Wound Care
6.6.1.2 New Technology with Constant Innovation
6.6.1.3 Strong R&D Pipeline
6.6.2 Weaknesses
6.6.2.1 Small Start-up Companies Dominate the Market
6.6.2.2 Expensive Technology
6.6.2.3 High Barriers to Entry
6.6.3 Opportunities
6.6.3.1 Strong Innovation will Drive Growth
6.6.3.2 Stem Cells Offer Multiple Opportunities
6.6.3.3 Increasing Prevalence of Chronic Wounds
6.6.4 Threats
6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.6.4.2 High Barriers to Entry will Deter Competitors
6.6.4.3 Competition from MWC and Devices

7. The Top Companies in the North American Advanced Wound Care Market, 2013-2023

7.1 3M
7.1.1 Sales and Performance Analysis, 2012
7.1.2 Regional Sales Analysis, 2012
7.1.3 R&D Performance Analysis, 2012
7.1.4 AWC Product Portfolio, 2013
7.2 ConvaTec
7.2.1 Sales and Performance Analysis, 2012
7.2.2 Wound Therapeutics Sales Analysis, 2012
7.2.3 R&D Performance Analysis, 2012
7.2.4 AWC Product Portfolio, 2013
7.2.5 Recent M&A Activity
7.3 Covidien
7.3.1 Sales and Performance Analysis, 2012
7.3.2 Regional Sales Analysis, 2012
7.3.3 R&D Performance Analysis, 2012
7.3.4 AWC Product Portfolio, 2013
7.3.5 Recent M&A Activities
7.4 Derma Sciences
7.4.1 Sales and Performance Analysis, 2012
7.4.2 Advanced Wound Care Sales Analysis, 2012
7.4.3 R&D Performance Analysis, 2012
7.4.4 AWC Product Portfolio, 2013
7.4.5 Recent M&A Activity
7.4.5.1 Derma Sciences Acquired MedEfficiency Inc.,
7.5 Hollister Incorporated
7.5.1 AWC Product Portfolio, 2013
7.6 Human Biosciences Inc.,
7.6.1 AWC Product Portfolio, 2013
7.7 Kinetic Concepts Inc (KCI)
7.7.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn
7.7.2 KCI Continues to Dominate NPWT Market
7.7.3 AWC Product Portfolio, 2013
7.7.4 Recent M&A and Other Key Activities
7.7.4.1 Acquisition of MoMelan Technologies Inc in 2012
7.7.4.2 KCI Expands its Operations to Brazil
7.8 Medline Industries, Inc.
7.8.1 AWC Product Portfolio, 2013
7.9 Organogenesis
7.9.1 Apligraf, A Promising Wound Healing Product
7.9.2 FDA Approves GINTUIT

8. The Top Companies in the European Advanced Wound Care Market, 2013-2023

8.1 Avita Medical
8.1.1 Sales and Performance Analysis, 2012
8.1.2 Product Portfolio, 2013
8.2 B.Braun Melsungen AG
8.2.1 Sales and Performance Analysis, 2012
8.2.2 AWC Product Portfolio, 2013
8.3 BSN Medical
8.3.1 AWC Product Portfolio, 2013
8.4 Coloplast
8.4.1 Coloplast Sales and Performance Analysis, 2012
8.4.2 Regional Sales Analysis, 2012
8.4.3 R&D Performance Analysis, 2012
8.4.4 Wound and Skin Care Sales Analysis, 2011/2012
8.4.5 AWC Product Portfolio, 2013
8.5 Genzyme (A Sanofi Company)
8.5.1 Epicel
8.6 HARTMANN GROUP
8.6.1 Sales and Performance Analysis, 2012
8.6.2 Regional Sales Analysis, 2012
8.6.3 AWC Product Portfolio, 2013
8.7 Laboratoires Urgo
8.7.1 Urgo Medical
8.7.2 AWC Product Portfolio, 2013
8.7.3 Recent M&A and Key Activities
8.7.3.1 Hollister Inc Continues Business Relation with Laboratories Urgo
8.8 Molnlycke Health Care
8.8.1 Sales and Performance Analysis, 2012
8.8.2 AWC Product Portfolio, 2013
8.8.3 Recent M&A Activity
8.8.3.1 Molnlycke Acquires WoundEL from Gerromed GmbH
8.8.3.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical
8.9 Shire
8.9.1 Sales and Performance Analysis, 2012
8.9.2 Shire Regenerative Medicine
8.9.3 DERMAGRAFT Sales Analysis, 2012
8.10 Smith & Nephew (S&N)
8.10.2 Advanced Wound Management Sales Analysis, 2012
8.10.3 Regional Sales Analysis, 2012
8.10.4 R&D Performance Analysis, 2012
8.10.5 AWC Product Portfolio, 2013
8.10.6 Smith & Nephew Pipeline
8.10.7 Recent M&A and Other Key Activities
8.10.7.1 Smith & Nephew Acquires Healthpoint Biotherapeutics
8.10.7.2 Purchase of Aderma Dermal Pads
8.10.7.3 Smith & Nephew Acquires Kalypto Medical
8.10.7.4 Regulatory Approvals in Advanced Wound Management, 2012
8.11 Systagenix Wound Management
8.11.1 AWC Product Portfolio, 2013
8.11.2 Recent M&A and Other Key Activities
8.11.2.1 Systagenix Forms Strategic Partnership with Sorbion
8.11.2.2 Systagenix Extends Sponsorship Agreement with Team Sky
8.11.2.3 Systagenix Acquires O2 Insights Inc

9. Qualitative Analysis of the Advanced Wound Care Market, 2013-2023

9.1 Porter's Five Force Analysis
9.1.1 Rivalry Among Competitors
9.1.2 Threat of New Entrants
9.1.3 Power of Suppliers
9.1.4 Power of Buyers
9.1.5 Threat of Substitutes

10. Expert Opinion

10.1 Interview with Derma Sciences
10.1.1 Perspective of Advanced Wound Care Market
10.1.2 Unmet Needs of the Industry
10.1.3 Do FDA Regulations Stifle Innovation?
10.1.4 Role of Moist Wound Care in the Future
10.1.5 Market for MEDIHONEY in Moist Wound Care
10.1.6 Key Products Driving Company Growth
10.1.7 Efficacy of Honey in Comparison to Silver
10.2 Interview with Shire Regenerative Medicine
10.2.1 Perspective of Wound Care Biologics Market
10.2.2 Cost and Reimbursement Issues
10.2.3 Outlook for DERMAGRAFT

11. Conclusions

11.1 The Advanced Wound Care Market, 2012-2023
11.2 KCI Dominated the Advanced Wound Care Market in 2012
11.3 Leading Companies are Focused on Moist Wound Care Market
11.4 Smaller Start Up Companies Dominate the Wound Care Biologics Market

List of Tables

Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Advantages and Disadvantages of Moist Wound Care
Table 2.5 The Benefits and Risks of Skin Grafting
Table 3.1 Global Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.2 The Advanced Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.3 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2012-2017
Table 3.4 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2017-2023
Table 3.5 The Advanced Wound Care Market by Leading Companies: Revenue ($bn) and Market Shares (%), 2012
Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 4.2 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 4.3 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
Table 5.1 The Wound Care Devices Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 5.2 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR %), 2012-2017
Table 5.3 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.4 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.5 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.6 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.7 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.8 SWOT Analysis of the Wound Care Devices Market, 2013-2023
Table 6.1 The Wound Care Biologics Market: Revenue ($m) and Market Shares (%) by Segment, 2012
Table 6.2 The Wound Care Biologics Market Forecast ($m, AGR% CAGR%), 2012-2017
Table 6.3 The Wound Care Biologics Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.4 The Skin Replacement Market Forecast ($m, AGR% CAGR %), 2012-2017
Table 6.5 The Skin Replacement Market Forecast ($m, AGR%, CAGR %), 2017-2023
Table 6.6 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.7 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.8 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.9 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.10 SWOT Analysis of the Wound Care Biologics Market, 2013-2023
Table 7.1 3M: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 7.2 3M: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.3 3M: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.4 ConvaTec: Net Sales ($m) and Net Sales Share (%) by Franchise, 2012
Table 7.5 ConvaTec: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Net Sales (%), 2009-2012
Table 7.6 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.7 Covidien: Medical Supplies Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.8 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.9 Covidien: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.10 Covidien: Advanced Wound Care Product Portfolio, 2013
Table 7.11 Derma Sciences: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 7.12 Derma Sciences: Historical Advanced Wound Care Revenue ($m) and % Growth, 2007-2012
Table 7.13 Derma Sciences: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2008-2012
Table 7.14 VAC Therapy at a Glance, 2013
Table 8.1 Avita Medical: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.2 Avita Medical: Total Revenue ($m) in 2011 and 2012
Table 8.3 B.Braun: Sales ($bn) and Sales Shares (%) by Business Segment, 2012
Table 8.4 Coloplast: Revenue ($m) and Revenue Shares (%) by Business, 2011/2012
Table 8.5 Coloplast: Revenue ($m) and Revenue Shares (%) by Region, 2011/2012
Table 8.6 Coloplast: R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2007-2012
Table 8.7 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 8.8 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 8.9 Molnlycke: Historical Net Sales ($bn) and Net Debt ($bn), 2008-2012
Table 8.10 Shire: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 8.11 Shire: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.12 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Business Division, 2012
Table 8.13 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Franchise, 2012
Table 8.14 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 8.15 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 11.1 Segments in the Advanced Wound Care Market: Sales ($bn) in 2012, 2017, 2019 and 2023

List of Figures

Figure 2.1 The Phases of Wound Healing and Duration (Days)
Figure 3.1 Global Wound Care Market: Revenue ($bn) by Segment, 2012
Figure 3.2 Global Wound Care Market: Revenue Shares (%) by Segment, 2012
Figure 3.3 The Advanced Wound Care Market: Revenue ($bn) by Segment, 2012
Figure 3.4 The Advanced Wound Care Market: Revenue Shares (%) by Segment, 2012
Figure 3.5 The Advanced Wound Care Market Forecast ($bn), 2012-2023
Figure 3.6 The Advanced Wound Care Market Forecast ($bn) by Segment, 2012-2023
Figure 3.7 Drivers and Restraints for the Advanced Wound Care Market, 2013-2023
Figure 3.8 The Advanced Wound Care Market by Leading Companies: Revenue ($bn), 2012
Figure 3.9 The Advanced Wound Care Market by Leading Companies: Market Shares (%), 2012
Figure 4.1 The Moist Wound Care Market: Revenue ($bn) by Segment, 2012
Figure 4.2 The Moist Wound Care Market: Market Shares (%) by Segment, 2012
Figure 4.3 The Moist Wound Care Market Forecast ($bn), 2012-2023
Figure 5.1 The Wound Care Devices Market: Revenue ($bn) by Segment, 2012
Figure 5.2 The Wound Care Devices Market: Market Shares (%) by Segment, 2012
Figure 5.3 The Wound Care Devices Market Forecast ($bn), 2012-2023
Figure 5.4 The Wound Care Devices Market Forecast ($bn) by Segment, 2012-2023
Figure 5.5 The NPWT Market Forecast ($bn), 2012-2023
Figure 5.6 The Ultrasound Wound Therapy Market Forecast ($bn), 2012-2023
Figure 6.1 The Wound Care Biologics Market: Revenue ($m) by Segment, 2012
Figure 6.2 The Wound Care Biologics Market: Market Shares (%) by Segment, 2012
Figure 6.3 The Wound Care Biologics Market Forecast ($m), 2012-2023
Figure 6.4 The Skin Replacement Market Forecast ($m), 2012-2023
Figure 6.5 The Collagen Based Therapy Market Forecast ($m), 2012-2023
Figure 6.6 The Cell Therapy Market Forecast ($m), 2012-2023
Figure 7.1 3M: Historical Net Sales ($bn), Net Income ($bn) and Profit Margin (%), 2008-2012
Figure 7.2 3M: Net Sales ($bn) by Business Segment, 2012
Figure 7.3 3M: Historical Net Sales ($bn) in Healthcare Segment, 2012
Figure 7.4 3M: Net Sales ($bn) by Region, 2012
Figure 7.5 3M: Net Sales Shares (%) by Region, 2012
Figure 7.6 3M: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Figure 7.7 3M: Strengths and Threats, 2013-2023
Figure 7.8 ConvaTec: Historical Net Sales ($m) and Net Loss ($m), 2009-2012
Figure 7.9 ConvaTec: Net Sales ($m) by Franchise, 2012
Figure 7.10 ConvaTec: Net Sales Shares (%) by Franchise, 2012
Figure 7.11 ConvaTec: Historical Wound Therapeutics Net Sales ($m), 2009-2012
Figure 7.12 ConvaTec: Historical R&D Expenses ($m), R&D Expenses as Percentage of Net Sales (%), 2009-2012
Figure 7.13 ConvaTec: Strengths and Threats, 2013-2023
Figure 7.14 Covidien: Net Sales ($bn) by Segment, 2012
Figure 7.15 Covidien: Net Sales Shares (%) by Segment, 2012
Figure 7.16 Covidien: Historical Net Sales ($bn), Net Income ($bn) and Profit Margin (%), 2008-2012
Figure 7.17 Covidien: Medical Supplies Net Sales ($bn) by Segment, 2012
Figure 7.18 Covidien: Net Sales Shares (%) by Region, 2012
Figure 7.19 Covidien: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Figure 7.20 Covidien: Strengths and Threats, 2013-2023
Figure 7.21 Derma Sciences: Historical Revenue ($m) and Net Loss ($m), 2008-2012
Figure 7.22 Derma Sciences: Revenue ($m) by Segment, 2012
Figure 7.23 Derma Sciences: Revenue Shares (%) by Segment, 2012
Figure 7.24 Derma Sciences: Historical Advanced Wound Care Revenue ($m), 2007-2012
Figure 7.25 Derma Sciences: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2008-2012
Figure 7.26 Derma Sciences: Strengths and Threats, 2013-2023
Figure 7.27 Hollister Incorporated: Strengths and Threats, 2013-2023
Figure 7.28 Human BioSciences: Strengths and Threats, 2013-2023
Figure 7.29 KCI: Strengths and Threats, 2013-2023
Figure 7.30 Medline Industries, Inc.: Strengths and Threats, 2013-2023
Figure 7.31 Organogenesis: Strengths and Threats, 2013-2023
Figure 8.1 Avita Medical: Revenue Shares (%) by Segment, 2012
Figure 8.2 Avita Medical: Strengths and Threats, 2013-2023
Figure 8.3 B.Braun: Historical Sales ($bn), 2008-2012
Figure 8.4 B.Braun: Sales ($bn) by Business Segment, 2012
Figure 8.5 B.Braun: Sales Shares (%) by Business Segment, 2012
Figure 8.6 B.Braun: Strengths and Threats, 2013-2023
Figure 8.7 BSN Medical: Strengths and Threats, 2013-2023
Figure 8.8 Coloplast: Historical Revenue ($m), Net Income ($m) and Profit Margin (%), 2007-2012
Figure 8.9 Coloplast: Revenue ($m) by Business, 2011/2012
Figure 8.10 Coloplast: Revenue Shares (%) by Business, 2011/2012
Figure 8.11 Coloplast: Revenue ($m) by Region, 2011/2012
Figure 8.12 Coloplast: Revenue Shares (%) by Region, 2011/2012
Figure 8.13 Coloplast: R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2007-2012
Figure 8.14 Coloplast: Historical Wound Care and Skin Care Revenue ($m), 2007-2012
Figure 8.15 Coloplast: Strengths and Threats, 2013-2023
Figure 8.16 Genzyme: Strengths and Threats, 2013-2023
Figure 8.17 HARTMANN GROUP: Net Sales ($bn) by Business Segment, 2012
Figure 8.18 HARTMANN GROUP: Net Sales Shares (%) by Business Segment, 2012
Figure 8.19 HARTMANN GROUP: Historical Net Sales ($bn), 2008-2012
Figure 8.20 HARTMANN GROUP: Net Sales Shares (%) by Region, 2012
Figure 8.21 HARTMANN GROUP: Strengths and Threats, 2013-2023
Figure 8.22 Laboratoires Urgo: Strengths and Threats, 2013-2023
Figure 8.23 Molnlycke: Net Sales ($bn), 2008-2012
Figure 8.24 Molnlycke: Strengths and Threats, 2013-2023
Figure 8.25 Shire: Revenue Shares (%) by Segment, 2012
Figure 8.26 Shire: Revenue ($m) by Product Segment, 2012
Figure 8.27 Shire: Revenue Shares (%) by Product Segment, 2012
Figure 8.28 Shire: Strengths and Threats, 2013-2023
Figure 8.29 Smith & Nephew: Historical Revenue ($bn), 2008-2012
Figure 8.30 Smith & Nephew: Revenue ($bn) by Business Division, 2012
Figure 8.31 Smith & Nephew: Revenue Shares (%) by Business Division, 2012
Figure 8.32 Smith & Nephew: AWM Revenue ($bn) by Franchise, 2012
Figure 8.33 Smith & Nephew: AWM Market Shares (%) by Franchise, 2012
Figure 8.34 Smith & Nephew: AWM Revenue Shares (%) by Region, 2012
Figure 8.35 Smith & Nephew: Revenue Shares (%) by Region, 2012
Figure 8.36 Smith & Nephew: Historical Revenue ($bn), R&D Expenses ($bn) and R&D Expenses as Percentage of Revenue (%), 2008-2012
Figure 8.37 Smith & Nephew: Strengths and Threats, 2013-2023
Figure 8.38 Systagenix: Strengths and Threats, 2013-2023
Figure 9.1 Porter's Five Force Analysis of the Advanced Wound Care Market, 2013-2023
Figure 11.1 Advanced Wound Care Market: Sales ($bn) in 2012, 2017, 2019 and 2023
Figure 11.2 Advanced Wound Care Market: Sales ($bn) in 2012, 2017, 2019 and 2023

Companies Listed

180 Medical Holdings, Inc.
3M
Advanced BioHealing
Ahlcon Parenterals
Alpha Beta Enterprises Co Ltd
Arobella
Alere
Avista Capital Partners
Avita Medical
BARRX Medical, Inc.
B.Braun
Beiersdorf AG
BioMed Realty Trust, Inc.
BlueSky Medical Group
Boehringer Wound Systems
Boston Medical Division
Brennan Medical
Bristol-Myers Squibb
BSN Medical
Canada Pension Plan Investment Board (CPPIB)
Celleration
Cellerate Rx
Centre for Biologics Evaluation and Research (CBER)
Centre for Devices and Radiological Health (CDRH)
Centre for Medicare and Medicaid Services (CMS)
Ceradyne, Inc.
China's National Tissue Engineering Center (NTEC)
Clinical Cell Culture
CNS Therapeutics, Inc.
Coloplast
CodeRyte, Inc.
ConvaTec
Covidien
Derma Sciences
Devon Medicals
E.R Squibb & Sons
FerroKin Biosciences
Food and Drug Administration (FDA)
Focus Product Developments Ltd
Fraunofer Institute
Funny Hygiene AG
Garnet Biotherapeutics
Gentleheal ehf
Genzyme
Getinge AB
HARTMANN GROUP
Healthpoint Biotherapeutics
Hollister Wound Care
Human Biosciences
Investor AB
Kaken Pharmaceuticals
Kalypto Medical
Kinetic Concepts
Kneipp and NOGE Group
Laboratoires Urgo
Lescarden
Macrocure
Massachusetts Institute of Technology
Maya Medical
McGowan Institute for Regenerative Medicine
MindFrame, Inc.
MedEfficiency, Inc.
Medela
Medicare
Medline Industries
Mesynthes Ltd
Misonix
Molnlycke
MoMelan Technologies
Montagu Private Equity
Nanotherapeutics
Newport Medical Instruments, Inc.
Nordic Capital Partners
Novation
O2 Insights, Inc.
Organogenesis
Oridion Systems Ltd
Osiris Therapeutics
Pervasis Therapeutics, Inc.
Polyheal
Public Sector Pension Investment Board (PSP Investments)
SANUWAVE Health
Sanofi
Saudi Food and Drug Authority (SFDA)
Shire
Smith & Nephew
Sorbion
Soring
Spiracur, Inc.
Stanford University
SuperDimension Ltd
Systagenix
Tyco International
University of Missouri
University of Pittsburgh
Visomed
Walter Reed Army Medical Centre
Wake Forest University, US
Winterthur Technologie AG

To order this report: The Top 20 Companies In The Advanced Wound Care Market 2013-2023
http://www.reportlinker.com/p01657657/The-Top-20-Companies-In-The-Advanced-Wound-Care-Market-2013-2023.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker